Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

I’m 63 and have been diagnosed with atrial fibrillation. I wonder what you know about medical care and self-care for the ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

In a recent study explained in Medical News Today, weight loss surgery can significantly decrease the progression of kidney disease.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Covering weight-loss drugs for elderly Americans on the state-backed Medicare health insurance programme would cost the US government $35bn over the next nine years, a congressional analysis has found ...

Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.